Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yong-Hui Ding, Zhi-Wei Zhou, Chun-Fang Ha, Xue-Yu Zhang, Shu-Ting Pan, Zhi-Xu He, Jeffrey L Edelman, Dong Wang, Yin-Xue Yang, Xueji Zhang, Wei Duan, Tianxin Yang, Jia-Xuan Qiu & Shu-Feng Zhou. (2015) Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells. Drug Design, Development and Therapy 9, pages 425-464.
Read now
Read now
Articles from other publishers (18)
Kallesh D. Jayappa, Brian Tran, Vicki L. Gordon, Christopher Morris, Shekhar Saha, Caroline C. Farrington, Caitlin M. O’Connor, Kaitlin P. Zawacki, Krista M. Isaac, Mark Kester, Timothy P. Bender, Michael E. Williams, Craig A. Portell, Michael J. Weber & Goutham Narla. (2023) PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis. Journal of Clinical Investigation 133:13.
Crossref
Crossref
Fabian Stuhldreier, Laura Schmitt, Thomas Lenz, Ilka Hinxlage, Marcel Zimmermann, Philipp Wollnitzke, Julian Schliehe-Diecks, Yang Liu, Paul Jäger, Stefanie Geyh, Nicole Teusch, Christoph Peter, Sanil Bhatia, Rainer Haas, Bodo Levkau, Andreas S. Reichert, Kai Stühler, Peter Proksch, Björn Stork & Sebastian Wesselborg. (2022) The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism. Cell Death & Disease 13:11.
Crossref
Crossref
Ruchi P. Patel, Joanna R. Thomas, Katherine M. Curt, Christina M. Fitzsimmons, Pedro J. Batista, Susan E. Bates, Michael M. Gottesman & Robert W. Robey. (2021) Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma. Investigative Opthalmology & Visual Science 62:12, pages 16.
Crossref
Crossref
María G. Cortiguera, Lorena García-Gaipo, Simon D. Wagner, Javier León, Ana Batlle-López & M. Dolores Delgado. (2019) Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells. Scientific Reports 9:1.
Crossref
Crossref
Rehmat Jan & Gul-e-Saba Chaudhry. (2019) Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics. Advanced Pharmaceutical Bulletin 9:2, pages 205-218.
Crossref
Crossref
Andrew J. McDonald, Katherine M. Curt, Ruchi P. Patel, Hanna Kozlowski, Dan L. Sackett, Robert W. Robey, Michael M. Gottesman & Susan E. Bates. (2019) Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor models. Experimental Cell Research 375:2, pages 106-112.
Crossref
Crossref
Jong Kook Park, Jung Seon Seo, Suk Kyeong Lee, Kenneth K Chan & Hyo-Jeong Kuh. (2018) Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells. Biomolecules & Therapeutics 26:6, pages 591-598.
Crossref
Crossref
Benjamin Onyeagucha, Panneerdoss Subbarayalu, Nourhan Abdelfattah, Subapriya Rajamanickam, Santosh Timilsina, Rosa Guzman, Carla Zeballos, Vijay Eedunuri, Sanjay Bansal, Tabrez Mohammad, Yidong Chen, Ratna K. Vadlamudi & Manjeet K. Rao. (2017) Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die. Oncotarget 8:49, pages 85984-85996.
Crossref
Crossref
Liya Su, Qimuge Suyila, Ling Yang, Hong Li, Yaguang Xi & Xiulan Su. (2017) Bax is involved in the anticancer activity of Velcade in colorectal cancer. Experimental and Therapeutic Medicine 14:4, pages 3179-3183.
Crossref
Crossref
Monish R. Makena, Balakrishna Koneru, Thinh H. Nguyen, Min H. Kang & C. Patrick Reynolds. (2017) Reactive Oxygen Species–Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies. Molecular Cancer Therapeutics 16:4, pages 649-661.
Crossref
Crossref
Carmine Carbone, Elena Di Gennaro, Geny Piro, Maria Rita Milone, Biagio Pucci, Michele Caraglia & Alfredo Budillon. (2016) Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat. Amino Acids 49:3, pages 517-528.
Crossref
Crossref
Julian C. Bahr, Robert W. Robey, Victoria Luchenko, Agnes Basseville, Arup R. Chakraborty, Hanna Kozlowski, Gary T. Pauly, Paresma Patel, Joel P. Schneider, Michael M. Gottesman & Susan E. Bates. (2016) Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget 7:43, pages 69804-69815.
Crossref
Crossref
Maria Joosten, Sebastian Ginzel, Christian Blex, Dmitri Schmidt, Michael Gombert, Cai Chen, René Martin Linka, Olivia Gräbner, Anika Hain, Burkhard Hirsch, Anke Sommerfeld, Anke Seegebarth, Uschi Gruber, Corinna Maneck, Langhui Zhang, Katharina Stenin, Henrik Dieks, Michael Sefkow, Carsten Münk, Claudia D. Baldus, Ralf Thiele, Arndt Borkhardt, Michael Hummel, Hubert Köster, Ute Fischer, Mathias Dreger & Volkhard Seitz. (2016) A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma. Molecular Oncology 10:8, pages 1232-1244.
Crossref
Crossref
Zhiqing Liu, Ye Ding, Na Ye, Christopher Wild, Haiying Chen & Jia Zhou. (2016) Direct Activation of Bax Protein for Cancer Therapy. Medicinal Research Reviews 36:2, pages 313-341.
Crossref
Crossref
Susan E. Bates, Robin Eisch, Alexander Ling, Douglas Rosing, Maria Turner, Stefania Pittaluga, H. Miles Prince, Mark H. Kirschbaum, Steven L. Allen, Jasmine Zain, Larisa J. Geskin, David Joske, Leslie Popplewell, Edward W. Cowen, Elaine S. Jaffe, Jean Nichols, Sally Kennedy, Seth M. Steinberg, David J. Liewehr, Louise C. Showe, Caryn Steakley, John Wright, Tito Fojo, Thomas Litman & Richard L. Piekarz. (2015) Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data. British Journal of Haematology 170:1, pages 96-109.
Crossref
Crossref
Susan E. Bates, Robert W. Robey & Richard L. Piekarz. (2015)
CCR
20th Anniversary Commentary: Expanding the Epigenetic Therapeutic Portfolio
. Clinical Cancer Research 21:10, pages 2195-2197.
Crossref
Crossref
Lotte M.E. Berghauser Pont, Jochem K.H. Spoor, Subramanian Venkatesan, Sigrid Swagemakers, Jenneke J. Kloezeman, Clemens M.F. Dirven, Peter J. van der Spek, Martine L.M. Lamfers & Sieger Leenstra. (2014) The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells. Genes & Cancer 5:11-12, pages 445-459.
Crossref
Crossref
Owen A. O'Connor, Govind Bhagat, Karthik Ganapathi, Martin Bjerregaard Pedersen, Francesco D'Amore, Dejan Radeski & Susan E. Bates. (2014) Changing the Paradigms of Treatment in Peripheral T-cell Lymphoma: From Biology to Clinical Practice. Clinical Cancer Research 20:20, pages 5240-5254.
Crossref
Crossref